1. Home
  2. KIRK vs SCYX Comparison

KIRK vs SCYX Comparison

Compare KIRK & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KIRK
  • SCYX
  • Stock Information
  • Founded
  • KIRK 1966
  • SCYX 1999
  • Country
  • KIRK United States
  • SCYX United States
  • Employees
  • KIRK N/A
  • SCYX N/A
  • Industry
  • KIRK Diversified Commercial Services
  • SCYX Biotechnology: Pharmaceutical Preparations
  • Sector
  • KIRK Miscellaneous
  • SCYX Health Care
  • Exchange
  • KIRK Nasdaq
  • SCYX Nasdaq
  • Market Cap
  • KIRK 26.7M
  • SCYX 28.5M
  • IPO Year
  • KIRK 2002
  • SCYX 2014
  • Fundamental
  • Price
  • KIRK $1.21
  • SCYX $0.71
  • Analyst Decision
  • KIRK Buy
  • SCYX
  • Analyst Count
  • KIRK 2
  • SCYX 0
  • Target Price
  • KIRK $4.50
  • SCYX N/A
  • AVG Volume (30 Days)
  • KIRK 193.4K
  • SCYX 142.0K
  • Earning Date
  • KIRK 09-04-2025
  • SCYX 08-07-2025
  • Dividend Yield
  • KIRK N/A
  • SCYX N/A
  • EPS Growth
  • KIRK N/A
  • SCYX N/A
  • EPS
  • KIRK N/A
  • SCYX N/A
  • Revenue
  • KIRK $431,111,000.00
  • SCYX $2,630,000.00
  • Revenue This Year
  • KIRK N/A
  • SCYX $463.61
  • Revenue Next Year
  • KIRK N/A
  • SCYX $310.80
  • P/E Ratio
  • KIRK N/A
  • SCYX N/A
  • Revenue Growth
  • KIRK N/A
  • SCYX N/A
  • 52 Week Low
  • KIRK $1.05
  • SCYX $0.66
  • 52 Week High
  • KIRK $2.50
  • SCYX $2.29
  • Technical
  • Relative Strength Index (RSI)
  • KIRK 56.05
  • SCYX 38.69
  • Support Level
  • KIRK $1.16
  • SCYX $0.67
  • Resistance Level
  • KIRK $1.23
  • SCYX $0.75
  • Average True Range (ATR)
  • KIRK 0.04
  • SCYX 0.04
  • MACD
  • KIRK 0.01
  • SCYX 0.00
  • Stochastic Oscillator
  • KIRK 88.72
  • SCYX 33.06

About KIRK Kirkland's Inc. COMMONSTOCK

Kirkland's Inc is a specialty retailer of home decor and gifts in the United States. The company stores provide various merchandise, including holiday decor, value pricing, and a stimulating in-store and online environment that provides customers with a brand experience. The company stores also offer an assortment of holiday merchandise in seasonal periods, as well as items that are suitable for gift-giving.

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

Share on Social Networks: